Tratamiento y manejo actual de la fase aguda de la enfermedad de peyronie

Translated title of the contribution: Currant treatmant and management of the acute phase of Peyronle's disease

Alex J. Vanni, Nelson E. Bennett

Research output: Contribution to journalArticlepeer-review

4 Scopus citations

Abstract

The true pathophysiologic nature of Peyronie's disease continues to evolve. This pathology often results in a penile plaque(s), penile deformity, curvature, pain, and erectile dysfunction. Clinically, there are two distinct phases, acute and chronic. The focus of this review will center on the management of the acute phase of Peyronie's disease. While little data exists demonstrating disease resolution, disease stabilization is an important clinical goal for patients as this often allows acceptable sexual function. Thus, medical management during the acute phase of Peyronie's disease is aimed at limiting and stabilizing the degree of penile fibrosis, decreasing penile curvature, and reducing penile pain. In this manuscript we explain different therapies; oral, topical, intralesional injection and others like extracorporeal shockwave (ESWT), radiation and penile traction for acute phase of Peyronie's disease. Although no consensus exists for the treatment of acute phase Peyronie's disease, a majority of patients can achieve stabilization and in some cases regression of their disease with proper medical therapy. The goals of therapy should be discussed extensively with each patient, noting that erectile function will be likely despite some degree of curvature.

Translated title of the contributionCurrant treatmant and management of the acute phase of Peyronle's disease
Original languageSpanish
Pages (from-to)614-622
Number of pages9
JournalArchivos Espanoles de Urologia
Volume62
Issue number8
StatePublished - Oct 1 2009

Keywords

  • Erectile dysfunction
  • Peyronie's disease

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Currant treatmant and management of the acute phase of Peyronle's disease'. Together they form a unique fingerprint.

Cite this